A recent study out of Canada highlights the lack of advancement in treatment for pleural mesothelioma.
Diagnosis with the cancer, caused by exposure to asbestos, typically leads to survival expectancies of nine to 10 months. Treatment to extend survival time is a main advancement the study shows has not come to fruition.
The study reviewed three types of treatment for mesothelioma:
- Indwelling pleural catheters,
- Chemotherapy, and
While the study determined a lack of advancement in these treatment methods, it also stated that immunotherapy could be a promising future treatment.